Anticoagulation effect of LMWH combination with warfarin in treatment of intracranial venous sinus thrombosis at early stage
- VernacularTitle:低分子肝素联合华法林早期抗凝治疗颅内静脉窦血栓的效果
- Author:
Yan JIAO
;
Fengmei DUAN
;
Hongyan LI
- Publication Type:Journal Article
- Keywords:
low molecular weight heparin;
warfarin;
intracranial venous sinus;
blood clots;
curative effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;35(10):93-95
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the anticoagulation effect of low molecular weight heparin (LMWH) combination with warfarin at the early stage at the treatment of intracranial venous sinus thrombosis.Methods 80 cases of intracranial venous sinus thrombosis patients in people's hospital of Xinjiang Uygur autononous region from January 2010 to December 2014 were chosen to be analyzed retrospectively.37 cases in observation group were treated with low molecular heparin (LMWH) in combination with warfarin, and 43 cases in control group were treated with warfarin.The clinical curative effect between two groups was compared post-treatment.Results The effective rate in observation group was 91.89%, which was significantly higher than 67.44% in control group (P<0.05) .The recanalization rate of involved intracerebral venous in observation group was 89.19%, which was significantly higher than 67.29% in control group(P<0.05).After treatment, the prothrombin time (PT), thrombin time (TT) and activated partial thromboplastin time (APTT) were higher and fibrinogen (FBG) in both groups was lower than those pre-treatment(P<0.05).The PT and APTT was higher and FBG was lower in observation group than those in control group(P<0.05).Conclusion Low molecular weight heparin in combination with warfarin worked well than single warfarin in the treatment of intracranial venous sinus thrombosis.
